Your browser doesn't support javascript.
loading
Erratum to: Modeling precision treatment of breast cancer.
Daemen, Anneleen; Griffith, Obi L; Heiser, Laura M; Wang, Nicholas J; Enache, Oana M; Sanborn, Zachary; Pepin, Francois; Durinck, Steffen; Korkola, James E; Griffith, Malachi; Hur, Joe S; Huh, Nam; Chung, Jongsuk; Cope, Leslie; Fackler, Mary Jo; Umbricht, Christopher; Sukumar, Saraswati; Seth, Pankaj; Sukhatme, Vikas P; Jakkula, Lakshmi R; Lu, Yiling; Mills, Gordon B; Cho, Raymond J; Collisson, Eric A; Van't Veer, Laura J; Spellman, Paul T; Gray, Joe W.
Afiliação
  • Daemen A; Department of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. daemena@gene.com.
  • Griffith OL; Laboratory Medicine, University of California San Francisco, San Francisco, CA, 94115, USA. daemena@gene.com.
  • Heiser LM; Present address: Department of Bioinformatics & Computational Biology, Genentech Inc, 1 DNA Way, South San Francisco, CA, 94080, USA. daemena@gene.com.
  • Wang NJ; Department of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. ogriffit@genome.wustl.edu.
  • Enache OM; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, 97239, USA. ogriffit@genome.wustl.edu.
  • Sanborn Z; The Genome Institute, Washington University School of Medicine, St Louis, MO, 63105, USA. ogriffit@genome.wustl.edu.
  • Pepin F; Department of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. heiserl@ohsu.edu.
  • Durinck S; Department of Biomedical Engineering, Center for Spatial Systems Biomedicine, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, 97239, USA. heiserl@ohsu.edu.
  • Korkola JE; Department of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. wangnic@ohsu.edu.
  • Griffith M; Department of Biomedical Engineering, Center for Spatial Systems Biomedicine, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, 97239, USA. wangnic@ohsu.edu.
  • Hur JS; Department of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. oenache@berkeley.edu.
  • Huh N; Five3 genomics, 101 Cooper St, Santa Cruz, CA, 95060, USA. zack@five3genomics.com.
  • Chung J; Department of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. francois.pepin@sequenta.com.
  • Cope L; Present address: Sequenta Inc, South San Francisco, CA, 94080, USA. francois.pepin@sequenta.com.
  • Fackler MJ; Department of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. sdurinck@gmail.com.
  • Umbricht C; Department of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. korkola@ohsu.edu.
  • Sukumar S; Department of Biomedical Engineering, Center for Spatial Systems Biomedicine, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, 97239, USA. korkola@ohsu.edu.
  • Seth P; The Genome Institute, Washington University School of Medicine, St Louis, MO, 63105, USA. mgriffit@genome.wustl.edu.
  • Sukhatme VP; Samsung Electronics Headquarters, Seocho-gu, Seoul, 137-857, Korea. joe.hur@samsung.com.
  • Jakkula LR; Emerging Technology Research Center, Samsung Advanced Institute of Technology, Kyunggi-do, 446-712, Korea. namhuh@samsung.com.
  • Lu Y; Emerging Technology Research Center, Samsung Advanced Institute of Technology, Kyunggi-do, 446-712, Korea. doogie.chung@samsung.com.
  • Mills GB; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. Lcope1@jhmi.edu.
  • Cho RJ; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. facklma@jhmi.edu.
  • Collisson EA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. cumbrich@jhmi.edu.
  • Van't Veer LJ; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. saras@jhmi.edu.
  • Spellman PT; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. pseth@bidmc.harvard.edu.
  • Gray JW; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. vsukhatm@bidmc.harvard.edu.
Genome Biol ; 16: 95, 2015 May 12.
Article em En | MEDLINE | ID: mdl-25962591
ABSTRACT
During the type-setting of the final version of the article [1] some of the additional files were swapped. The correct files are republished in this Erratum.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Genome Biol Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Genome Biol Ano de publicação: 2015 Tipo de documento: Article